GuruFocus Insider Data
, these are the largest insider buys during the past week: AbbVie
), Abbot Laboratories (
), Yum! Brands Inc. (
), and Aetna Inc. (
The overall trend of insiders is illustrated in the chart below:
AbbVie Inc. (
): Director Frederick H. Waddell Bought 2,000 Shares
Director of AbbVie Inc., Frederick H. Waddell, bought 2,000
shares on 2/04/2013 at an average price of $36.22. AbbVie Inc.
has a market cap of $57.28 billion; its shares were traded at
around $36.22 with and P/S ratio of 3.1756. The dividend yield of
AbbVie Inc. stocks is 1.1%.
On Jan. 30, AbbVie confirmed it delivered strong sales growth
with its marketed pharmaceutical products in 2012. The
proprietary pharmaceutical segment of Abbott, representing the
majority of AbbVie's revenue, grew more than 8 percent globally
on an operational basis, excluding a nearly 3 percent negative
impact from foreign exchange.
Abbott Laboratories (
): Director William A. Osborn Bought 15,000 Shares
Director of Abbott Laboratories, William A. Osborn, bought 15,000
shares during the past week at an average price of $34.42. Abbott
Laboratories is an Illinois corporation, incorporated in 1900.
Abbott Laboratories has a market cap of $54.39 billion; its
shares were traded at around $34.42 with a P/E ratio of 8.3682
and P/S ratio of 1.386. The dividend yield of Abbott Laboratories
stocks is 4.85%. Abbott Laboratories had an annual average
earnings growth of 8.9% over the past 10 years. GuruFocus rated
the business predictability rank of 3-star
On Jan. 23, Abbott announced financial results for the fourth
quarter ended Dec. 31, 2012. Fourth-quarter diluted earnings per
share, excluding specified items, were $1.51. Diluted earnings
per share under Generally Accepted Accounting Principles (GAAP)
were $0.66, including specified items. Full-year diluted earnings
per share, excluding specified items, were $5.07, exceeding
Abbott's initial guidance range. Diluted earnings per share under
GAAP were $3.72, including specified items.
Last week, Director
William A. Osborn
bought 10,000 shares of ABT stock. Senior Vice President
Stephen R. Fussell
sold 9,690 shares this month. Executive Vice President Laura J.
Schumacher and Senior Vice President A. David Forrest sold shares
in December, and Chairman and CEO Miles D. White sold shares in
Yum! Brands Inc. (
): Director Robert D. Walter Bought 35,000 Shares
Director of Yum! Brands Inc., Robert D. Walter, bought 35,000
shares on 2/06/2013 at an average price of $65.37. Yum! Brands
Inc. was incorporated under the laws of the state of North
Carolina in 1997. Yum! Brands Inc. has a market cap of $29.5
billion; its shares were traded at around $65.37 with a P/E ratio
of 19.2308 and P/S ratio of 2.2857. The dividend yield of Yum!
Brands Inc. stocks is 1.9%. Yum Brands Inc. had an annual average
earnings growth of 10.3% over the past 10 years.
On Feb. 4, Yum! Brands Inc. reported results for the fourth
quarter ended Dec. 29, 2012 including EPS of $0.83, excluding
Special Items. Reported EPS was $0.72 for the quarter and $3.38
for the year.
Last week, Director Robert D. Walter bought 35,000 shares of YUM
stock. Senior Vice President and Chief Public Affairs Jonathan
David Blum sold 3,242 shares this month. Senior Vice President
and Chief Public Affairs Jonathan David Blum sold 3,244 shares in
January. Director Massimo Ferragamo, Chief People Officer Hollan
Anne Byerlein, Chair and CEO China Division Jingshyh S. Su and
Senior Vice President Finance and CFO Richard Carucci sold shares
Aetna Inc. (
): Executive Vice President, Local/Regional Bus Karen Rohan
Bought 4,035 Shares
Executive Vice President, Local/Regional Bus of Aetna Inc., Karen
Rohan, bought 4,035 shares on 02/06/2013 at an average price of
$50.56. Aetna Inc. was incorporated in Pennsylvania in 1982 under
the name of United States Health Care Systems Inc. Aetna Inc. has
a market cap of $16.93 billion; its shares were traded at around
$50.56 with a P/E ratio of 9.6712 and P/S ratio of 0.5052. The
dividend yield of Aetna Inc. stocks is 1.43%. Aetna Inc. had an
annual average earnings growth of 22.7% over the past 10 years.
GuruFocus rated Aetna Inc. the business predictability rank of
On Jan. 31, Aetna announced fourth-quarter 2012 operating
earnings of $317.0 million, or $.94 per share. Full-year 2012
operating earnings were $1.77 billion, or $5.13 per share. Net
income for the fourth quarter of 2012 was $190.1 million, or $.56
per share, and includes $.44 per share of charges for other
items, primarily a litigation-related settlement, offset by $.06
per share of net realized capital gains. Full-year net income was
$1.66 billion, or $4.81 per share.
Last week, Executive Vice President, Local/Regional Business
Karen Rohan bought 4,035 shares of AET stock. Director Molly Joel
Coye, Director Edward J. Ludwig, Senior Vice President and
General Counsel William James Casazza, Vice President, Controller
and Chief Accounting Officer Rajan Parmeswar, and Chairman, CEO
and President Mark T. Bertolini sold shares in December.
For the complete list of stocks that were bought by their company
executives, go to: Insider Buys.About GuruFocus: GuruFocus.com
tracks the stocks picks and portfolio holdings of the world's
best investors. This value investing site offers stock screeners
and valuation tools. And publishes daily articles tracking the
latest moves of the world's best investors. GuruFocus also
provides promising stock ideas in 3 monthly newsletters sent to